CoChat

Differentiating Embryonic Stem Cells Pass through ‘Temporal Windows’ That Mark Responsiveness to Exogenous and Paracrine Mesendoderm Inducing Signals

Open access

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Mesendoderm induction during embryonic stem cell (ESC) differentiation in vitro is stimulated by the Transforming Growth Factor and Wingless (Wnt) families of growth factors. PRINCIPAL FINDINGS: We identified the periods during which Bone Morphogenetic Protein (BMP) 4, Wnt3a or Activin A were able to induce expression of the mesendoderm marker, Mixl1, in differentiating mouse ESCs. BMP4 and Wnt3a were required between differentiation day (d) 1.5 and 3 to most effectively induce Mixl1, whilst Activin A induced Mixl1 expression in ESC when added between d2 and d4, indicating a subtle difference in the requirement for Activin receptor signalling in this process. Stimulation of ESCs with these factors at earlier or later times resulted in little Mixl1 induction, suggesting that the differentiating ESCs passed through 'temporal windows' in which they sequentially gained and lost competence to respond to each growth factor. Inhibition of either Activin or Wnt signalling blocked Mixl1 induction by any of the three mesendoderm-inducing factors. Mixing experiments in which chimeric EBs were formed between growth factor-treated and untreated ESCs revealed that BMP, Activin and Wnt signalling all contributed to the propagation of paracrine mesendoderm inducing signals between adjacent cells. Finally, we demonstrated that the differentiating cells passed through 'exit gates' after which point they were no longer dependent on signalling from inducing molecules for Mixl1 expression. CONCLUSIONS: These studies suggest that differentiating ESCs are directed by an interconnected network of growth factors similar to those present in early embryos and that the timing of growth factor activity is critical for mesendoderm induction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0010706

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Mesendoderm inducing activity of BMP4 is restricted to a specific temporal window during ESC differentiation. (A) Flow cytometric analysis of d5 Mixl1 GFP/w ESCs differentiated in cultures supplemented with 10 ng/ml BMP4 for 24 h with the time of initial growth factor addition to the culture staggered at daily intervals starting at d0 (upper panels) or day 0.5 (lower panels). The proportion of GFP+ cells in this experiment is shown in the lower right of each plot. Flow cytometry profiles from no growth factor (-GF) control cultures are shown to the left of each series. (B) Histograms summarising flow cytometry data from three independent experiments, showing the average percentage of GFP+ cells at d5 observed for each period of BMP4 addition. (mean±sd, n = 3).
Figure 1 Mesendoderm inducing activity of BMP4 is restricted to a specific temporal window during ESC differentiation. (A) Flow cytometric analysis of d5 Mixl1 GFP/w ESCs differentiated in cultures supplemented with 10 ng/ml BMP4 for 24 h with the time of initial growth factor addition to the culture staggered at daily intervals starting at d0 (upper panels) or day 0.5 (lower panels). The proportion of GFP+ cells in this experiment is shown in the lower right of each plot. Flow cytometry profiles from no growth factor (-GF) control cultures are shown to the left of each series. (B) Histograms summarising flow cytometry data from three independent experiments, showing the average percentage of GFP+ cells at d5 observed for each period of BMP4 addition. (mean±sd, n = 3).CC BY · PubMed Central
Figure 2 Mesendoderm inducing activities of BMP4, Wnt3a and Activin A are restricted to specific temporal windows during ESC differentiation. (A) Flow cytometry analysis at d5 of a representative experiment of Mixl1 GFP/w ESCs differentiated in cultures supplemented with 10 ng/ml BMP4, 100 ng/ml Wnt3a or 100 ng/ml Activin A for the indicated time intervals (measured in days after initiation of differentiation). The proportion of GFP+ cells is shown in the lower right of each plot. The flow cytometry profiles from no growth factor (-GF) control cultures are shown to the left of each series. (B) Histogram summarising flow cytometry data measuring the proportion of GFP+ cells at d5 in EBs treated with Wnt3a or Activin A during the time intervals indicated (days) (mean±sd, n = 3). (C) Brightfield and epifluorescence images of differentiating EBs. The growth factors and period of addition are indicated to the left of each row and day of differentiation when the image was taken in the top right hand corner of each panel. (Original magnification×100).
Figure 2 Mesendoderm inducing activities of BMP4, Wnt3a and Activin A are restricted to specific temporal windows during ESC differentiation. (A) Flow cytometry analysis at d5 of a representative experiment of Mixl1 GFP/w ESCs differentiated in cultures supplemented with 10 ng/ml BMP4, 100 ng/ml Wnt3a or 100 ng/ml Activin A for the indicated time intervals (measured in days after initiation of differentiation). The proportion of GFP+ cells is shown in the lower right of each plot. The flow cytometry profiles from no growth factor (-GF) control cultures are shown to the left of each series. (B) Histogram summarising flow cytometry data measuring the proportion of GFP+ cells at d5 in EBs treated with Wnt3a or Activin A during the time intervals indicated (days) (mean±sd, n = 3). (C) Brightfield and epifluorescence images of differentiating EBs. The growth factors and period of addition are indicated to the left of each row and day of differentiation when the image was taken in the top right hand corner of each panel. (Original magnification×100).CC BY · PubMed Central
Figure 3 Induction of maximal proportions of GFP+ Mixl1GFP/w cells requires signalling via BMP, Wnt and Activin receptor pathways. (A) Flow cytometry analysis at d5 of a representative experiment of Mixl1 GFP/w ESCs differentiated in cultures supplemented with BMP4 (d1–d5), Wnt3a (d1–d5) or Activin A (d2–d5) alone or in the presence of the signalling pathway inhibitors noggin, Dkk-1 or SB 431542. Growth factors are shown to the left of each row and inhibitors are shown at the top of each column. Flow cytometry profiles obtained from control cells with no growth factor added (-GF) are shown in the bottom left panel. The percentage of GFP+ positive cells is recorded in the bottom right corner of each plot. (B) Histogram summarising flow cytometry data measuring the proportion of GFP+ cells at d5 in EBs treated with BMP4, Wnt3a or Activin A with and without inhibitors. (mean±sd, n = 3) (* p<0.05, ** p<0.01 compared to cells not receiving inhibitor). SB; SB 431542. (C) Semi-quantitative RT-PCR analysis of growth factor gene expression in cells from d3 cultures stimulated with BMP4 (d1–d3), Wnt3a (d1–d3) or Activin A (d2–d3). The samples are indicated at the top of each column and the growth factor genes analysed on the left of each row. ESC; undifferentiated ESCs, -GF; no growth factor, Act A; Activin A, H2O; no template control. (D) Real time PCR analysis of BMP4, Wnt3 and nodal gene expression at d3 in ESCs differentiated in the presence of BMP4 (d1.5–d3), Wnt3a (d1.5–d3) and Activin A (d2–d3). (mean±sem, n = 3). (* p<0.05, ** p<0.01 compared to samples collected from cells differentiated in the absence of growth factor.)
Figure 3 Induction of maximal proportions of GFP+ Mixl1GFP/w cells requires signalling via BMP, Wnt and Activin receptor pathways. (A) Flow cytometry analysis at d5 of a representative experiment of Mixl1 GFP/w ESCs differentiated in cultures supplemented with BMP4 (d1–d5), Wnt3a (d1–d5) or Activin A (d2–d5) alone or in the presence of the signalling pathway inhibitors noggin, Dkk-1 or SB 431542. Growth factors are shown to the left of each row and inhibitors are shown at the top of each column. Flow cytometry profiles obtained from control cells with no growth factor added (-GF) are shown in the bottom left panel. The percentage of GFP+ positive cells is recorded in the bottom right corner of each plot. (B) Histogram summarising flow cytometry data measuring the proportion of GFP+ cells at d5 in EBs treated with BMP4, Wnt3a or Activin A with and without inhibitors. (mean±sd, n = 3) (* p<0.05, ** p<0.01 compared to cells not receiving inhibitor). SB; SB 431542. (C) Semi-quantitative RT-PCR analysis of growth factor gene expression in cells from d3 cultures stimulated with BMP4 (d1–d3), Wnt3a (d1–d3) or Activin A (d2–d3). The samples are indicated at the top of each column and the growth factor genes analysed on the left of each row. ESC; undifferentiated ESCs, -GF; no growth factor, Act A; Activin A, H2O; no template control. (D) Real time PCR analysis of BMP4, Wnt3 and nodal gene expression at d3 in ESCs differentiated in the presence of BMP4 (d1.5–d3), Wnt3a (d1.5–d3) and Activin A (d2–d3). (mean±sem, n = 3). (* p<0.05, ** p<0.01 compared to samples collected from cells differentiated in the absence of growth factor.)CC BY · PubMed Central
Figure 4 ES Cells differentiated in response to BMP4 or Wnt3a generate paracrine signals that induce GFP in Mixl1 GFP/w EBs. (A) Method used to assess the ability of ‘stimulator’ wild type Mixl1 w/w ESCs differentiated in the presence of growth factors to induce expression of GFP in ‘responder’ Mixl1 GFP/w ESCs differentiated in absence of exogenous growth factors. After 3d of differentiation, both ‘stimulator’ and ‘responder’ EBs were disaggregated and chimeric spin EBs formed by re-aggregating ‘stimulator’ and ‘responder’ cells in a 1∶1 ratio. After allowing differentiation to proceed for a further 2d in the absence of growth factors the chimeric EBs were harvested for analysis. (B) Flow cytometry analysis of d5 chimeric EBs. The growth factors used for the ‘stimulator’ and ‘responder’ cultures for the initial 3d of differentiation are shown above each panel of a representative experiment (stimulator/responder). All ‘responder’ differentiations were performed in the absence of added growth factors (/-GF). The flow cytometry profiles obtained using ‘stimulator’ cells not exposed to growth factor (-GF/-GF) are shown as a negative control. The percentage of GFP+ cells is shown. (C) Histogram summarising the flow cytometry data at d5 (mean ±sd, n = 3). (D) Flow cytometry analysis of d5 chimeric EBs formed by aggregating growth factor stimulated wild type Mixl1 w/w with unstimulated Mixl1 GFP/w differentiating ESCs at d3. At the time of aggregation, inhibitors of BMP (noggin), canonical Wnt (Dkk-1) and Activin receptor (SB 431542) signalling were added to the cultures. Growth factors used to stimulate the wild type ESCs from d0–d3 are shown to the left of each row. Inhibitors are shown at the top of each column. Flow cytometry profiles obtained with cells from the no growth factor (-GF) control cultures are shown. The percentage of GFP+ positive cells is recorded in the bottom right corner of each plot. SB; SB 431542.
Figure 4 ES Cells differentiated in response to BMP4 or Wnt3a generate paracrine signals that induce GFP in Mixl1 GFP/w EBs. (A) Method used to assess the ability of ‘stimulator’ wild type Mixl1 w/w ESCs differentiated in the presence of growth factors to induce expression of GFP in ‘responder’ Mixl1 GFP/w ESCs differentiated in absence of exogenous growth factors. After 3d of differentiation, both ‘stimulator’ and ‘responder’ EBs were disaggregated and chimeric spin EBs formed by re-aggregating ‘stimulator’ and ‘responder’ cells in a 1∶1 ratio. After allowing differentiation to proceed for a further 2d in the absence of growth factors the chimeric EBs were harvested for analysis. (B) Flow cytometry analysis of d5 chimeric EBs. The growth factors used for the ‘stimulator’ and ‘responder’ cultures for the initial 3d of differentiation are shown above each panel of a representative experiment (stimulator/responder). All ‘responder’ differentiations were performed in the absence of added growth factors (/-GF). The flow cytometry profiles obtained using ‘stimulator’ cells not exposed to growth factor (-GF/-GF) are shown as a negative control. The percentage of GFP+ cells is shown. (C) Histogram summarising the flow cytometry data at d5 (mean ±sd, n = 3). (D) Flow cytometry analysis of d5 chimeric EBs formed by aggregating growth factor stimulated wild type Mixl1 w/w with unstimulated Mixl1 GFP/w differentiating ESCs at d3. At the time of aggregation, inhibitors of BMP (noggin), canonical Wnt (Dkk-1) and Activin receptor (SB 431542) signalling were added to the cultures. Growth factors used to stimulate the wild type ESCs from d0–d3 are shown to the left of each row. Inhibitors are shown at the top of each column. Flow cytometry profiles obtained with cells from the no growth factor (-GF) control cultures are shown. The percentage of GFP+ positive cells is recorded in the bottom right corner of each plot. SB; SB 431542.CC BY · PubMed Central
Figure 5 BMP4, Wnt and Activin signalling are required after d3 for maximal GFP induction from Mixl1 GFP/w EBs. (A) Flow cytometry analysis of GFP expression in d5 Mixl1 GFP/w EBs stimulated with BMP4 (d1–3), Wnt3a (d1–3) or Activin A (d2–3) and subsequently treated from d3–5 with the inhibitors noggin, Dkk-1 or SB 431542. SB; SB 431542. (B) Histogram summarising d5 flow cytometry data (mean±sd, n = 3) (* p<0.05, ** p<0.01 compared to cells not receiving inhibitor). SB; SB 431542. (C, D) Gene expression analysis of (C) d3 and (D) d5 differentiating mESCs treated with exogenous BMP4, Wnt3a and Activin A. The growth factor and treatment days are indicated across the top of each sample. Samples to which the Activin signalling inhibitor SB 431542 was added are indicated (SB), as are control samples that were treated with DMSO carrier (DM). The genes analysed are shown on the left hand side of each row.
Figure 5 BMP4, Wnt and Activin signalling are required after d3 for maximal GFP induction from Mixl1 GFP/w EBs. (A) Flow cytometry analysis of GFP expression in d5 Mixl1 GFP/w EBs stimulated with BMP4 (d1–3), Wnt3a (d1–3) or Activin A (d2–3) and subsequently treated from d3–5 with the inhibitors noggin, Dkk-1 or SB 431542. SB; SB 431542. (B) Histogram summarising d5 flow cytometry data (mean±sd, n = 3) (* p<0.05, ** p<0.01 compared to cells not receiving inhibitor). SB; SB 431542. (C, D) Gene expression analysis of (C) d3 and (D) d5 differentiating mESCs treated with exogenous BMP4, Wnt3a and Activin A. The growth factor and treatment days are indicated across the top of each sample. Samples to which the Activin signalling inhibitor SB 431542 was added are indicated (SB), as are control samples that were treated with DMSO carrier (DM). The genes analysed are shown on the left hand side of each row.CC BY · PubMed Central
Figure 6 Wnt3a and Activin A synergise to induce GFP in Mixl1 GFP/w EBs. (A) Flow cytometry analysis at d5 of a representative experiment of Mixl1 GFP/w ESCs differentiated in cultures supplemented with 100 ng/ml Wnt3a (W) and/or 100 ng/ml Activin A (A) from the time indicated. The no growth factor (-GF) control is shown to the left. (B) Histogram summarising the d5 flow cytometry data from Mixl1 GFP/w ESCs differentiated in cultures supplemented with the indicated growth factors from the time indicated. (mean±sd, n = 3) (* p<0.05 compared to d3A). B; BMP4, W; Wnt3a, A; Activin A.
Figure 6 Wnt3a and Activin A synergise to induce GFP in Mixl1 GFP/w EBs. (A) Flow cytometry analysis at d5 of a representative experiment of Mixl1 GFP/w ESCs differentiated in cultures supplemented with 100 ng/ml Wnt3a (W) and/or 100 ng/ml Activin A (A) from the time indicated. The no growth factor (-GF) control is shown to the left. (B) Histogram summarising the d5 flow cytometry data from Mixl1 GFP/w ESCs differentiated in cultures supplemented with the indicated growth factors from the time indicated. (mean±sd, n = 3) (* p<0.05 compared to d3A). B; BMP4, W; Wnt3a, A; Activin A.CC BY · PubMed Central
Figure 7 Induction of Mixl1 expression is regulated through the integration of signals from BMP, Wnt and Activin/nodal pathways. (A) Interactions between signalling pathways and inhibitors impacting upon Mixl1 induction. BMP4 stimulates expression of Wnt and Activin/nodal, which in turn induce Mixl1, perhaps acting through as yet unidentified intermediate molecules. The time periods (in days) and differentiation stages during which the differentiating ES cells are responsive to each stimulus are indicated. Probable autocrine (A) and paracrine (P) roles of the factors are indicated. (B) Removal of factors maintaining pluripotency enables ES cells to differentiate and to respond to BMP4, Wnt3a or Activin A signals delivered during a defined ‘temporal window’ for mesendoderm induction. (C) After cells pass through the mesendoderm window at d3, they then pass through ‘exit gates’ for each signalling pathway, after which time they are no longer dependent on that pathway for mesendoderm induction. In response to BMP4 addition between d1.5 and d3, the approximate percentage of cells that have passed the BMP4, Wnt3a or Activin A ‘exit gates’ at d3 is shown. See text for more details (Data taken from Figure 5B).
Figure 7 Induction of Mixl1 expression is regulated through the integration of signals from BMP, Wnt and Activin/nodal pathways. (A) Interactions between signalling pathways and inhibitors impacting upon Mixl1 induction. BMP4 stimulates expression of Wnt and Activin/nodal, which in turn induce Mixl1, perhaps acting through as yet unidentified intermediate molecules. The time periods (in days) and differentiation stages during which the differentiating ES cells are responsive to each stimulus are indicated. Probable autocrine (A) and paracrine (P) roles of the factors are indicated. (B) Removal of factors maintaining pluripotency enables ES cells to differentiate and to respond to BMP4, Wnt3a or Activin A signals delivered during a defined ‘temporal window’ for mesendoderm induction. (C) After cells pass through the mesendoderm window at d3, they then pass through ‘exit gates’ for each signalling pathway, after which time they are no longer dependent on that pathway for mesendoderm induction. In response to BMP4 addition between d1.5 and d3, the approximate percentage of cells that have passed the BMP4, Wnt3a or Activin A ‘exit gates’ at d3 is shown. See text for more details (Data taken from Figure 5B).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Askanazy M 1907 Die teratome nach ihrem bau, ihrem verlauf, ihren genese und im vergleich zum experimentellen teratoid. Verhandl Deutsch Pathol 11 39 82

Cited by

See all 73

Metadata

Authors
Jackson, S. A., Schiesser, J., Stanley, E. G., & Elefanty, A. G.
Affiliations
Monash University (AU)
Corresponding author
Elefanty, Andrew G.
Venue
PLoS ONE
Published
2010-05-19
Volume
5
Issue
5
Pages
e10706
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2078093070
Cited by
67
References
62
Citations by year
2025: 1 · 2024: 2 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 5 · 2017: 7 · 2016: 8 · 2015: 2 · 2014: 10 · 2013: 6 · 2012: 9
FWCI
3.25
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
Funders
  • Medical Research Council
  • National Health and Medical Research Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
Keywords
embryonic stem cell differentiation, mesendoderm induction, temporal window, BMP4, Wnt3a, activin A, Mixl1, paracrine signaling, mouse embryonic stem cells
MeSH terms
Animals, Cell Differentiation, Embryo, Mammalian, Endoderm, Time Factors, Signal Transduction, Gene Expression Regulation, Developmental, Paracrine Communication, Activins, Intercellular Signaling Peptides and Proteins, Green Fluorescent Proteins, Wnt Proteins, Mice, Embryonic Stem Cells, Bone Morphogenetic Protein 4, Wnt3 Protein, Wnt3A Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.